A Fluorescence‐based assay for screening β‐lactams targeting the Mycobacterium tuberculosis transpeptidase LdtMt2
Mycobacterium tuberculosis L,D‐transpeptidases (Ldts), which are involved in cell wall biosynthesis, have emerged as promising targets for the treatment of tuberculosis. However, an efficient method for testing inhibition of these enzymes is not currently available. We present a fluorescence‐based a...
Main Authors: | De Munnik, M, Lohans, C, Langley, G, Bon, C, Brem, J, Schofield, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2019
|
Similar Items
-
Targeting the Mycobacterium tuberculosis transpeptidase LdtMt2 with cysteine-reactive inhibitors including ebselen
by: De Munnik, M, et al.
Published: (2019) -
High-throughput screen with the l,d-transpeptidase LdtMt2 of Mycobacterium tuberculosis reveals novel classes of covalently reacting inhibitors
by: de Munnik, M, et al.
Published: (2023) -
Non‐Hydrolytic β‐Lactam Antibiotic Fragmentation by l,d‐Transpeptidases and Serine β‐Lactamase Cysteine Variants
by: Lohans, C, et al.
Published: (2018) -
Biochemical and crystallographic studies of l,d -transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate
by: de Munnik, M, et al.
Published: (2024) -
The development of non-β-lactam inhibitors of bacterial transpeptidases
by: Suits, TF
Published: (2022)